Quick Answer
OneMedNet Corp reported Research And Development Expense of $1.52 million for the year ending 2025.
- OneMedNet Corp showed an increase of +3.3% in Research And Development Expense from 2024 to 2025.
- This data is from OneMedNet Corp's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2023: $582.0 thousand | Q2 2023: $579.0 thousand | Q3 2023: $405.0 thousand | Q1 2024: $445.0 thousand | Q2 2024: $383.0 thousand | Q3 2024: $298.0 thousand | Q1 2025: $348.0 thousand | Q2 2025: $382.0 thousand | Q3 2025: $323.0 thousand.
- Over the full 4 years of available data (2022 to 2025), OneMedNet Corp's Research And Development Expense has grown by 59.0%.
- Historical annual values: Fiscal year 2025: $1.52 million | Fiscal year 2024: $1.47 million | Fiscal year 2023: $2.07 million | Fiscal year 2022: $952.7 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: